Rezension:
Another year protodioscin extract Last year, nearly 1,000 cancer drugs were in clinical development, up 52% from 2006, says the Pharmaceutical Research and Manufacturers of America, a trade group. The \"vast majority\" of that growth is from drugs targeted at genetic mutations, says Bill Chin, the group\'s head of science and regulatory affairs.
